Glenn Schulman | SVP, Corporate Communications & IR |
Peter Greenleaf | President, CEO & Director |
Neil Solomons | Chief Medical Officer |
Max Colao | Chief Commercial Officer |
Joseph Miller | CFO |
Michael Martin | Co-Founder & COO |
Alethia Young | Cantor Fitzgerald & Co. |
Kenneth Cacciatore | Cowen and Company |
Joseph Schwartz | SVB Leerink |
Justin Kim | Oppenheimer |
Antonio Arce | H.C. Wainwright & Co. |
Maurice Raycroft | Jefferies |
Tom Bishop | BI Research |
Greetings, and welcome to the Aurinia Pharmaceuticals First Quarter 2020 Results Conference Call. [Operator Instructions].
It is now my pleasure to introduce your host, Dr. Glenn Schulman, Head of IR.
Thank you, Jesse, and good afternoon, everyone.